<?xml version="1.0" encoding="UTF-8"?>
<p>Adverse events data were shown in Table 
 <xref rid="cas14841-sup-0001" ref-type="supplementary-material">S4</xref>. In aCRCS A1 + B1, the incidence of grade 3 or higher adverse events of leucopenia, anemia, febrile neutropenia, and thromboembolism was significantly higher in the IRI group than in the OX group. Grade 3 or higher peripheral sensory neuropathy was only observed in the OX group in all aCRCS subtypes.
</p>
